‘A mess across the board’: Senate committee kicks off talks on drug pricing reforms
The US is still the only country in the world that doesn’t negotiate pharmaceutical prices across the board, experts told a Senate committee on Tuesday, but how exactly to fix that remains unclear and few of the solutions discussed will surprise anyone watching the pricing debate play out over the last decade.
Setting the tone for the hearing, which featured comments from a type 1 diabetes patient, Elia Spates, who has seen her insulin costs triple over about a decade, Sen. Bernie Sanders (I-VT) honed in on the fact that Spates is not alone, and 1 out of 5 Americans could not afford their prescription drugs last year.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.